Boston Scientific (BSX) – Business Wire
-
Volato Announces Changes to Board Composition
-
Axonics Stockholders Approve Merger Agreement with Boston Scientific
-
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
-
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
-
NACD New England honors Waters Corp. and Devoted Health as Public and Private Company “Boards of the Year”
-
Nordson Corporation Appoints Milton Morris to Board of Directors
-
AtriCure Names Two New Members to the Board of Directors
-
AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer
-
Alydia Announces $13.9 Million Financing for Innovative Postpartum Hemorrhage Treatment, Appoints Robert Binney as CEO and Colby Holtshouse as COO
-
Kevin Ballinger to Assume CEO Role at Aldevron; Michael Chambers to become Executive Chairman
-
AtriCure Names Two Industry Veterans to Board of Directors
-
Endologix Announces Exclusive Distributor Agreement with Boston Scientific for the Chinese Market
Back to BSX Stock Lookup